Medical Marijuana Market is expected to reach US$ 83.18 billion by 2033 | Top key players - Tilray, Aurora Cannabis, Aphria, Inc.

Market Size and Growth:

The Global Medical Marijuana Market size reached US$ 15.24 billion in 2024 is expected to reach US$ 83.18 billion by 2033, growing at a CAGR of 20.9% during the forecast period 2025-2033. The Market growth is driven by increasing legalization of medical cannabis worldwide and rising adoption for chronic pain, cancer, and neurological disorder treatments.

To Download a Free Sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/medical-marijuana-market?sz

The Medical Marijuana Market involves the cultivation, processing, distribution, and use of cannabis and its derivatives for therapeutic purposes. It includes products such as dried cannabis, oils, tinctures, and edibles prescribed for conditions like chronic pain, epilepsy, cancer, and multiple sclerosis, driven by increasing legalization, clinical research, and growing patient acceptance worldwide.

Industry Recent Developments: United States

✅ August 2025: The US cannabis market continues rapid growth backed by increased state-level legalization, medical applications, consumer acceptance, and innovations in retail infrastructure. The market is projected to reach $91.10 billion by 2033. Notably, New York saw a major correction in dispensary license location approvals, affecting 105 existing licensed dispensaries and 47 pending applicants, with legislative and relief fund measures under development to address the issue. Electronic inventory tracking systems became mandatory but implementation deadlines were paused recently.

✅ September 2025: Minnesota launched its adult-use cannabis program and held lotteries for cannabis retail licenses including social equity applicants. Legislative proposals targeted psilocybin therapy regulation and adult home cultivation of cannabis. Retailers expressed concerns over increased gross receipts tax on cannabis products.

Industry Recent Developments: Japan

✅ September 2025: The medical cannabis market in Japan is expanding, driven by rising acceptance of Convention on Biological Diversity-based products, particularly among the aging population seeking treatments for chronic pain, insomnia, and neurological disorders.

✅ October 2025: Following significant reforms to cannabis control laws, Japan is entering what is described as its "Hemp Era," with increasing public awareness, investment interest, and growing research collaborations. However, challenges remain including lack of physician training and strict regulations, but technology integration such as AI and blockchain is expected to drive future growth and streamline regulatory compliance.

Get Customization in the report as per your requirements + Exclusive Bundle & Multi-User Discounts: https://datamintelligence.com/customize/medical-marijuana-market?sz

Major Mergers & Acquisitions (2025):

✅ Industry M&A remained active but deal-driven by consolidation and distress - well-capitalized players acquiring smaller operators and single-state operators as capital tightened and the market consolidated. Analysts describe 2025 M&A activity as acquisition-heavy among larger firms taking on distressed or regional assets.

✅ Notable example: High Tide announced acquisitions/entry into the German medical cannabis market (Purecan GmbH) - one of several cross-border and strategic deals during the period.

Regulatory Approvals (2025):

✅ United Kingdom (Novel foods): The UK Food Standards Agency progressed several Convention on Biological Diversity novel-food dossiers in early 2025 - advancing multiple applications from safety assessment into risk management (a notable regulatory step for thousands of Convention on Biological Diversity products in market channels).

✅ Enforcement / recalls: Regulators and state authorities continued active product oversight - e.g., Curaleaf issued a voluntary recall (yeast/mold levels) in 2025 and state regulators publicly oversaw testing/recall procedures, underscoring ongoing quality-control enforcement in regulated markets.

Major Key Players:

Tilray
Aurora Cannabis
Canopy Growth Corporation
Aphria, Inc
Maricann Group, Inc
Tikun Olam, Ltd
MedReleaf. Corp
GW Pharmaceuticals plc
Cannabis Sativa, Inc
Medical Marijuana, Inc.

Segments Covered in the Medical Marijuana Market:

By Product Type: Flower/Buds, Oils & Tinctures, Capsules & Tablets, Topicals (creams, ointments), Others.

By Application: Pain Management, Neurological Disorders, Oncology, Mental Health Disorders, Gastrointestinal Disorders, Others.

By Route of Administration: Oral, Inhalation, Topical, Sublingual.

By End User: Hospitals, Clinics, Home Care / Patients, Research Institutes.

Regional Analysis for Medical Marijuana Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=medical-marijuana-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Medical Marijuana market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Medical Marijuana Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Medical Marijuana market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Medical Marijuana Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Medical Marijuana market?

➠ Who are the global key manufacturers of the Medical Marijuana Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Medical Marijuana market opportunities and threats faced by the vendors in the global Medical Marijuana Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Medical Marijuana market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.